ARTICLE | Clinical News
p17/p24:Ty-VLP HIV vaccine: The NIH's AIDS vaccine evaluation group began a Phase I trial to assess cellular immunity by killer T cells and levels of anti-HIV a
June 19, 1995 7:00 AM UTC
The trial will enroll 36 volunteers at low risk for HIV infection. ...